iAnthus closes on acquisition of New Jersey medical cannabis operation

Multistate operator iAnthus said Thursday it closed on the acquisition of a 100% equity interest in MPX New Jersey, a medical cannabis company in the state.

The deal helps pave the way for iAnthus, which has offices in Toronto and New York, to take advantage of New Jersey’s forthcoming recreational marijuana market.

MJBizFactbook projects the market will reach $2 billion in annual sales by the fourth full year.

New Jersey regulators approved the acquisition on Jan. 7, according to an iAnthus news release.

Control of the lucrative marijuana operation had been the subject of a legal proceeding.

Thursday’s news release doesn’t mention that case, but an iAnthus regulatory filing states that the legal matter was resolved and closed in March 2021.

In February 2021, iAnthus raised $11 million from a debt offering with the intent to make significant improvements at the MPX cultivation and processing facility in Pleasantville, New Jersey.

Expert advice for a stronger shelf life

Learn the fundamentals for getting started in cannabis retail in this comprehensive guide curated by the editors at MJBizDaily with help from industry experts.

Inside the MJBizDaily Retail Buyers Guide:
  • Learn best practices for designing a cannabis dispensary.
  • Select display infrastructure that supports industry compliance.
  • Choose the right point-of-sale system for your operation.
  • How to incorporate e-commerce and home delivery.
  • And more!

 

The company said it also plans to open a dispensary in Atlantic City in the next few months.

As disclosed in a December news release, iAnthus still needs regulatory approvals in several states for a previously announced financial restructuring and recapitalization plan.